Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, October 25, 2014
Technology Networks
 
Register | Sign in
Home Page > Videos > Advances in Volatile Analyses for Disease Diagnosis
  Videos

Return

Advances in Volatile Analyses for Disease Diagnosis
SELECTBIO

Health care organisations are under strain worldwide due to population increase particularly due to an aging population and also increased expectations from patients. Rapid, low cost and very accurate diagnoses using bio-analytical techniques will be of considerable benefit, especially if tests can be undertaken by relatively unskilled personnel. Very accurate diagnoses with population screening should enable early diagnoses of bladder and other cancers, and this may come about by a combination of tests identifying genes, proteins and smaller, volatile metabolites. Volatile analysis is particularly interesting as a relatively inexpensive platform device based on sensor technology could be used in principle for diagnosing a range of medical conditions where different volatile patterns are indicative of specific medical conditions. There also exists the possibility for sensor array and GC-Sensor devices to be miniaturised whereby the entire measurement system could potentially be incorporated on single micro-electromechanical systems (MEMS) based chips. This lecture will review the latest advances in volatile analyses for disease diagnosis.

Request more information
Company product page



For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here

Scientific News
IDT Shares Tips for Optimizing Target Capture
The article discusses improved target capture methods for increasing reliability of next generation sequencing data.
CDC Develops a New, Faster Lab Test for Enterovirus D68
Confirmed cases will appear to rise as agency accelerates specimen testing.
New 'Lab-on-a-Chip' Could Revolutionize Early Diagnosis of Cancer
Faster result times, reduced costs, minimal sample demands and better sensitivity of analysis.
NanoString, Brigham and Women’s Hospital Collaborate
Research collaboration to accelerate translation of genomic discoveries into clinical diagnostics in oncology.
Biologists Find An Early Sign Of Cancer
Patients show boost in certain amino acids years before diagnosis of pancreatic cancer.
New DNA Sequencing Method to Diagnose Tuberculosis
Teams aim to test the metagenomics technique on a wide range of samples.
Inivata Raises £4m to Realize the Potential of ctDNA Analysis
New spin-out from Cancer Research UK launched with funding from Imperial Innovations, Cambridge Innovation Capital and Johnson & Johnson Development Corporation.
Blood Test May Help Determine Psychosis Risk
A study led by University of North Carolina at Chapel Hill researchers represents an important step forward in the accurate diagnosis of people who are experiencing the earliest stages of psychosis.
Asuragen’s Xpansion Interpreter® Test Study of 1,040 Transmissions of Fragile X Alleles
Study reveals personalized risks for expansion from parent to child.
Blood Test To Diagnose Depression
Test identifies nine blood markers tied to depression; predicts who will benefit from therapy.
Scroll Up
Scroll Down
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv